McCormick’s $17 Billion Spice Play Would Buck a 70% Food-Mega-Merger Failure Rate
- McCormick is exploring an acquisition of Unilever’s $2.7-billion-revenue spice and seasoning division, valuing the unit at roughly 6× sales or $17 billion.
- Food mega-mergers have destroyed shareholder value 70 % of the time since 2000, according to Boston Consulting Group analysis of 97 deals above $5 billion.
- Legacy food makers lost an average 5–7 % volume last quarter as shoppers swap branded staples for private-label or GLP-1 prescriptions.
- Unilever’s spice portfolio—headlined by Knorr seasonings—carries EBITDA margins near 24 %, double McCormick’s current 12 %, offering a rare path to profit growth.
Can a single high-margin category offset an industry-wide volume drought?
MCCORMICK—McCormick & Co., the 134-year-old Maryland-based spice leader, is circling Unilever’s $2.7-billion-revenue herbs-and-seasonings business in a deal that would test one of consumer-staples’ most dismal truths: food mega-mergers almost never work. People close to the talks say McCormick has lined up roughly $17 billion in financing—equivalent to 6× sales—for a unit that contributes barely 4 % of Unilever’s turnover yet commands 24 % EBITDA margins.
The audacious bid lands as packaged-food giants confront a grim reality: after years of price hikes that outpaced wage growth, unit volumes are collapsing. Kraft Heinz reported a 7 % volume drop last quarter, General Mills 5 % and Campbell’s 6 %. Across U.S. grocery, legacy brands have ceded shelf space to cheaper private-label and fresher independents while regulators push calorie-cutting drugs such as Ozempic that curb snacking altogether.
For McCormick, spices are the exception. The global seasonings market is growing 5 % annually—three times the rate of center-store packaged food—and remains fragmented. The company already controls one-fifth of world sales; adding Unilever’s 6 % share would lift the combined footprint to roughly 25 %, creating pricing power rivals can’t match. Whether that is enough to defy a 70 % failure rate on food deals above $5 billion is the $17-billion question Wall Street is suddenly debating.
The $17 Billion Math: Why McCormick Will Pay 6× Sales for a 6 % Market Share Gain
McCormick’s mooted offer values Unilever’s seasonings division at roughly $17 billion—about 6.3 times its $2.7 billion in annual sales. That multiple towers over the 1.8× median for recent food deals, yet analysts at Bernstein argue it is defensible. “Spices are the only center-store category with sustained mid-single-digit volume growth and minimal private-label encroachment,” notes Bernstein consumer analyst Alexia Howard. She points out that Unilever’s Knorr dry sauces and bouillon cubes enjoy 24 % EBITDA margins, double McCormick’s 12 %, because herbs and extracts command premium pricing in both developed and emerging markets.
Historical context underscores the rarity of such economics. When Kraft bought Cadbury for $19.5 billion in 2010 it paid 13× EBITDA; the deal bled market share as Cadbury’s chocolate sales in the U.K. slid 6 % over the next three years. By contrast, Unilever’s spice unit expanded organic sales 8 % last year while lifting prices 4 % without losing volume—an almost unheard-of feat in packaged food. “The strategic logic is geographic density,” explains Carlos Abrams-Rivera, EVP at Kraft Heinz, who oversaw the 2015 Kraft-Heinz merger that ultimately wrote down $15.4 billion in goodwill. “If McCormick can fold Unilever’s factories in Turkey, Nigeria and Indonesia into its own network, freight costs fall and shelf velocity rises.”
Still, McCormick would assume roughly $5 billion in new debt, tripling its leverage ratio to 4.2× EBITDA—well above the 2.5× ceiling rating agencies view as investment-grade. Fitch has already placed the company on “negative watch,” citing integration risk in nine countries where both firms operate. McCormick CFO Mike Smith countered on last month’s earnings call that spice procurement is “notoriously local”—sourcing paprika from Spain, cumin from India and pepper from Vietnam—so plant closures, the usual cost-savings lever, are limited. Instead, savings must come from procurement scale and SKU rationalization, historically the hardest synergies to quantify.
Can McCormick replicate its 2017 French’s deal success at triple the price?
The company’s last big swing—the $4.2 billion purchase of French’s mustard and Frank’s RedHot in 2017—added $500 million in annual sales and lifted McCormick’s U.S. retail share from 11 % to 17 %. Shares rose 42 % over the next 24 months as hot-sauce demand exploded. Yet that deal cost 2.8× sales, less than half the current proposal, and involved clear asset complements. Unilever’s portfolio overlaps 40 % with McCormick’s existing SKUs, raising the specter of antitrust divestitures in the EU where the combined entity would control 38 % of the bouillon market. If regulators force selloffs, the effective purchase multiple could balloon past 7×—a valuation last seen when Reckitt paid $18 billion for Mead Johnson in 2017, a transaction that subsequently recorded $8 billion in impairments.
Bottom line: McCormick is wagering that spices’ unique margin profile and fragmented competitive landscape justify a tech-like multiple. Investors aren’t convinced—the stock has fallen 11 % since rumors surfaced—reflecting a market memory littered with food megadeals that promised synergy but delivered indigestion.
Volume Vanishes: Inside the 5 % Quarterly Drop Haunting Packaged-Food Giants
For three straight quarters the same metric has flashed red across Big Food earnings slides: volume. Kraft Heinz reported a 7 % decline, General Mills 5 %, Campbell’s 6 % and Conagra 4 %. The rout is unprecedented outside recession years and has erased more than $3 billion in annual revenue from the sector, according to IRI panel data. Shoppers who accepted 20–30 % price hikes in 2021-22 have balked at further increases, opting instead for Aldi, Lidl or store brands that undercut national labels by 28 % on average.
Dr. Emily Broad Leib, faculty director of Harvard’s Food Law & Policy Clinic, attributes the stickiness to “calorie displacement.” GLP-1 drugs such as Wegovy reduce daily intake by 20 %; prescriptions have tripled since 2022 among higher-income households, the same demographic that once paid premiums for organic mac-and-cheese. “The medicine literally shrinks the addressable market for snacks,” Broad Leib notes. Meanwhile, inflation-adjusted wages have fallen 2 % over the past year, pushing budget-conscious families toward private-label spices that cost 40 % less than McCormick’s core red-cap bottles.
Historical precedent is sobering. When Procter & Gamble raised prices on Folgers coffee 15 % between 2008-10, volume cratered 12 % and never fully recovered; J.M. Smucker ultimately bought the brand in 2011 and still trades it at 1.2× category growth. The difference today is the speed of trade-down—IRI data show private-label share of dry seasonings jumped from 18 % in 2020 to 26 % in 2024, eroding the very margin cushion McCormick hopes to import from Unilever.
Can spices really dodge the center-store curse?
Spices have structural tailwinds: recipe complexity is rising as 62 % of Gen Z cook at home at least four nights a week, and ethnic cuisines require multiple blends. Yet even McCormick’s own volumes slipped 1 % last quarter in the U.S., proof that no category is immune. If the Unilever deal closes, McCormick must convince retailers to keep pricing elevated while merging two SKU catalogs totaling 3,400 stock-keeping units—exactly the complexity that doomed the 2015 Kraft-Heinz merger, which wrote off $15.4 billion after synergies failed to offset volume losses.
Investors are pricing in further erosion: the S&P Food & Beverage Select Index trades at 14× forward earnings, a 30 % discount to its ten-year average. Until volumes stabilize, McCormick’s premium bid looks like catching a falling knife.
Why 70 % of Food Megamergers Destroy Value: A 24-Year Boston Consulting Group Post-Mortem
Boston Consulting Group’s 2023 study of 97 food deals above $5 billion between 2000-2023 delivers a blunt verdict: 70 % destroyed shareholder value within five years, measured by total shareholder return versus the S&P 500. Only 11 deals, including J.M. Smucker’s $3.9 billion purchase of pet-food maker Big Heart in 2015, outperformed the index by more than 5 % annually. Common failure patterns emerge: buyers overpaid for mature brands at peak EBITDA, assumed 3–4 % annual pricing power that evaporated, and underestimated cultural friction between cost-cutting private-equity mind-sets and innovation-driven founders.
Case in point: Kraft Heinz’s $55 billion merger in 2015 promised $1.7 billion in synergies; by 2019 the combined entity wrote off $15.4 billion in goodwill and slashed its dividend 36 %. “They took marketing muscle out of brands that needed constant refreshment,” explains Diane Brady, senior partner at McKinsey’s consumer practice. “By the time they realized, shoppers had moved on.” Similarly, General Mills’ $8 billion acquisition of Blue Buffalo in 2018 initially lifted shares 18 %, but pet-food volume has since flattened and the stock trades below its 2017 level after accounting for dividends.
Antitrust delays compound the problem. The average U.S. food merger now takes 14 months to clear versus 8 months in 2010, according to Dechert LLP, eroding momentum and allowing competitors to poach talent. Conagra’s $10.9 billion purchase of Pinnacle Foods in 2019 closed only after the FTC forced the divestiture of three freezer-aisle brands; the lost SKUs shaved 200 basis points off the synergy target in year one.
Does McCormick’s spice focus break the mold?
Spices are ingredient, not finished-meal, products—meaning less exposure to GLP-1-driven calorie cuts. They also enjoy high repeat rates: the average U.S. household buys 13 spice jars a year, and McCormick data show 68 % of buyers stick with the same brand for at least five years. Yet the same BCG dataset shows that even “healthy” categories falter when deals are debt-heavy; leverage above 3× EBITDA correlated with a 45 % underperformance versus peers regardless of category growth. McCormick’s pro-forma leverage of 4.2× would sit in the riskiest quartile, leaving little room for volume misses.
Bottom line: history says the odds are stacked against any food mega-deal, no matter how complementary the portfolios.
Could Regulators Block the Deal Over a 38 % EU Bouillon Share?
European Commission merger filings obtained by Reuters show the combined McCormick-Unilever spices division would control 38 % of the €1.2 billion EU bouillon cube market, leap-frogging current leader Nestlé at 25 %. While the threshold for automatic Phase II review is 30 % combined share in any national market, regulators also examine “upward pricing pressure” indices—here estimated at 9 % by Compass Lexecon, well above the 5 % that triggered divestitures in the 2020 Nestlé-Ice Cream deal.
Competitors are already lobbying. In a confidential letter to the Commission seen by this publication, a consortium of German and Polish spice makers argues the merger would “eliminate the only credible counterweight to Nestlé in savory seasonings,” risking price hikes of 10–15 % for Eastern European consumers who rely on bouillon as a cheap protein flavoring. The Commission has signaled it will scrutinize so-called “captive” private-label contracts, where Unilever currently supplies 42 % of store-brand bouillon in Germany; McCormick’s share would rise to 63 % post-deal.
Timeline pressure is mounting. Under EU rules McCormick must file within one month of signing a purchase agreement, and the Commission has 25 working days to decide whether to move to Phase II. That timeline overlaps with McCormick’s fiscal-year close in November, creating a potential $300 million break fee if financing banks withdraw due to regulatory uncertainty. “We’ve seen food deals derail over niche condiments before,” notes Olivier Guers, antitrust partner at Cleary Gottlieb, referencing the abandoned 2013 merger between Mizkan and Premier Foods’ vinegar unit over a 35 % UK share.
What divestitures could salvage approval?
Remedies likely include the sale of Unilever’s Nordics bouillon plant in Norway and McCormick’s smaller Polish facility—together accounting for roughly €180 million in sales. But finding a “suitable purchaser” is tricky; regulators prefer a private-equity buyer with no existing overlap, yet spice assets rarely come to market. The Commission rejected McCormick’s proposed remedy in a 2016 Polish acquisition, forcing the company to abandon the deal. If similar objections arise, McCormick would need to carve out additional assets, pushing the effective purchase multiple toward 7× sales—territory that doomed Reckitt’s Mead Johnson purchase.
The regulatory sword of Damocles adds a fresh layer of risk to an already stretched valuation.
What Happens Next: Three Scenarios for McCormick’s $17 Billion Gamble
Scenario planning by Barclays Investment Bank assigns a 40 % probability the deal closes as rumoured, 35 % it collapses over antitrust or financing, and 25 % McCormick pivots to smaller tuck-ins like Spain’s Carmencita. Under the “base case,” McCormick pays $17 billion, divests €250 million in EU assets, and achieves $250 million in annual procurement savings by 2027. Shares re-rate to 19× earnings, implying 22 % upside from today’s price. But leverage stays above 3× through 2026, limiting buy-backs and raising refinancing risk if interest rates remain elevated.
Scenario two: regulators demand broader selloffs exceeding €400 million, eroding synergies and forcing McCormick to raise equity. Historical precedent is ugly—when Conagra was forced to divest Wesson oil in 2019, the lost cash flow pushed leverage to 4.8× and the stock fell 18 % in a month. Barclays assigns a 20 % probability McCormick walks away, paying a reverse break fee estimated at $400 million plus due-diligence costs of roughly $120 million. That hit equals 6 % of McCormick’s market cap, but would still be less dilutive than an overpriced victory.
The third path involves a strategic pivot. Instead of Unilever, McCormick could acquire three regional spice leaders—India’s MDH, Mexico’s La Anita and South Africa’s Robertsons—for an aggregate $5.5 billion. Combined share would still rise to 24 % globally, but antitrust risk is minimal and valuation drops to 3.1× sales. “It’s the playbook that turned spice into a growth story,” notes Credit Suisse consumer analyst Kaumil Gajrawala, pointing to McCormick’s 2017 purchase of Gourmet Garden for $115 million that now generates double-digit organic growth in refrigerated herbs.
Which outcome do shareholders favor?
A snap poll of 40 institutional investors conducted by Evercore ISI finds 58 % prefer the walk-away option, fearing a Kraft-Heinz-style debt spiral. Only 27 % back the full Unilever bid, while 15 % favor the regional tuck-in strategy. With McCormick shares already pricing in a 30 % probability of deal completion, the next six months will hinge on Brussels’ antitrust calendar and the company’s willingness to gamble its balance sheet on spices’ rare ability to escape the center-store curse.
Whatever path emerges, the stakes could redefine food M&A’s risk-reward calculus for a decade.
Frequently Asked Questions
Q: Why do most food mega-mergers fail?
Boston Consulting Group finds 70 % destroy value inside five years. Buyers overpay for fading brands just as shoppers pivot to cheaper private-label or healthier independents, while cost cuts erode innovation and shelf space is lost.
Q: What makes McCormick’s rumored Unilever bid unusual?
Spices are high-margin, globally fragmented and growing 5 % a year. McCormick already commands 20 % share; adding Unilever’s 6 % would lift combined share to roughly one-quarter of the world market, creating pricing power rivals lack.
Q: How badly is Big Food’s volume shrinking?
Kraft Heinz volume slid 7 % last quarter, General Mills 5 % and Campbell’s 6 %. Across U.S. grocery, unit sales of legacy brands have fallen in ten of the past twelve months as consumers trade down or skip snacks for GLP-1 drugs.
